---
id: "patrick-soon-shiong"
name: "Patrick Soon-Shiong"
birth: "1952-07-29"
death: "Unknown"
nationality: "South African-American"
occupation: ["Entrepreneur", "Surgeon"]
image: ""
socialLinks:
  wikipedia: "https://en.wikipedia.org/wiki/Patrick_Soon-Shiong"
lastUpdated: "2026-02-21"
---

## Summary

Patrick Soon-Shiong is a South African-born American surgeon, billionaire, and biotechnology entrepreneur. He developed Abraxane, a breakthrough cancer drug, and founded NantHealth and NantWorks. He purchased the Los Angeles Times and the San Diego Union-Tribune in 2018 for $500 million. He is one of the wealthiest people in Los Angeles and a major figure in the intersection of medicine and technology.

## Career Timeline

| Year | Event |
|------|-------|
| 1952 | Born in Port Elizabeth, South Africa |
| 1991 | Founded VivoRx Inc. (transplantation) |
| 2005 | Abraxane cancer drug approved by FDA |
| 2010 | Sold Abraxis BioScience to Celgene for $2.9 billion |
| 2016 | Founded NantHealth |
| 2018 | Acquired Los Angeles Times for $500 million |
| 2024 | Continued biotech and media investments |

## References

[^1]: Wikipedia, "Patrick Soon-Shiong" - https://en.wikipedia.org/wiki/Patrick_Soon-Shiong
